Hematology

Study observes ‘trend toward efficacy’ with lanadelumab in pediatric patients with HAE

A study compared the safety and efficacy of lanadelumab versus another long-term prophylaxis treatment for hereditary angioedema (HAE) in pediatric patients and found a “trend toward greater efficacy and fewer adverse events” with lanadelumab. The systematic literature review included 2 studies and 29 patients aged <12 years with HAE—1 assessed...